Announced Thu, 28 May · 13:49 IST

We are enclosing herewith the following: Audited Financial Results for the Financial Year ended March 31, 2026, as per format prescribed under Regulation 33 of Securities Exchange Board ....

PGHH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.6%1-day move
₹10099.00
prior close
₹10115.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.5-2.9-4.0-4.6-6.6-7.0-7.4-7.2-6.9-10.7-7.4-12.6
Up moveDown movePending
AI summary

Procter & Gamble Hygiene and Health Care Ltd reported audited financial results for FY2026 (April 1, 2025 to March 31, 2026). Revenue from operations stood at ₹4,29,042 lakhs with profit after tax of ₹85,650 lakhs. EPS came in at ₹263.86 per share. The Board recommended a dividend of ₹60 per equity share (face value ₹10), payable on or before September 18, 2026, subject to shareholder approval. Operating cash flow was strong at ₹92,408 lakhs. The auditors (Kalyaniwalla & Mistry LLP) issued an unmodified (clean) opinion. Note: The company changed its financial year-end from June 30 to March 31, making current 12-month figures not directly comparable with the previous 9-month period (July 2024 to March 2025). Cash position strengthened to ₹55,702 lakhs from ₹46,637 lakhs.

Likely market impact

The clean audit opinion and strong cash generation indicate financial health. The dividend yield (₹60 on ₹10 face value) signals confidence. However, investors should note that year-over-year revenue and profit comparisons are distorted due to the change in financial year, requiring a full 12-month rolling comparison for accurate growth assessment.